Related references
Note: Only part of the references are listed.Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy
Boyi Niu et al.
BIOMATERIALS (2021)
Polymeric micelles in cancer therapy: State of the art
Balaram Ghosh et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies
Sepideh Mirzaei et al.
MOLECULES (2021)
Sanguinarine enhances cisplatin sensitivity via glutathione depletion in cisplatin-resistant ovarian cancer (A2780) cells
Roya Sarkhosh-Inanlou et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2020)
Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers
Ali Aghebati-Maleki et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Polyurea Dendrimer Folate-Targeted Nanodelivery of l-Buthionine Sulfoximine as a Tool to Tackle Ovarian Cancer Chemoresistance
Adriana Cruz et al.
ANTIOXIDANTS (2020)
Tumor microenvironment-induced structure changing drug/gene delivery system for overcoming delivery -associated challenges
Min Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Five insights from the Global Burden of Disease Study 2019
Christopher J L Murray et al.
LANCET (2020)
Cisplatin: The first metal based anticancer drug
Sumit Ghosh
BIOORGANIC CHEMISTRY (2019)
Unraveling the Potential Role of Glutathione in Multiple Forms of Cell Death in Cancer Therapy
Huanhuan Lv et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
The balance between NRF2/GSH antioxidant mediated pathway and DNA repair modulates cisplatin resistance in lung cancer cells
Matheus Molina Silva et al.
SCIENTIFIC REPORTS (2019)
Polydopamine-coated mesoporous silica nanoparticles for multi-responsive drug delivery and combined chemo-photothermal therapy
Wei Lei et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2019)
Biomimetic Metal-Organic Framework Nanoparticles for Cooperative Combination of Antiangiogenesis and Photodynamic Therapy for Enhanced Efficacy
Huan Min et al.
ADVANCED MATERIALS (2019)
Emerging platinum(IV) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment
Zhigang Wang et al.
DALTON TRANSACTIONS (2019)
Monochalcoplatin: An Actively Transported, Quickly Reducible, and Highly Potent Pt-IV Anticancer Prodrug
Lili Ma et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
The ferroptosis inducer erastin irreversibly inhibits system xc- and synergizes with cisplatin to increase cisplatin's cytotoxicity in cancer cells
Mami Sato et al.
SCIENTIFIC REPORTS (2018)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
Prodrugs in medicinal chemistry and enzyme prodrug therapies
Raoul Walther et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Antioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species
Long He et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
Timothy C. Johnstone et al.
CHEMICAL REVIEWS (2016)
Pathophysiological Basis for the Formation of the Tumor Microenvironment
Michael R. Horsman et al.
FRONTIERS IN ONCOLOGY (2016)
Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions
Steven B. Chinn et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine
George Mattheolabakis et al.
JOURNAL OF DRUG TARGETING (2015)
Mesoporous silica nanoparticles in drug delivery and biomedical applications
Ying Wang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
Nicolas Bertrand et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Cellular mechanisms and physiological consequences of redox-dependent signalling
Kira M. Holmstroem et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Glutathione synthesis
Shelly C. Lu
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
Fangqiong Tang et al.
ADVANCED MATERIALS (2012)
Combating the Drug Resistance of Cisplatin Using a Platinum Prodrug Based Delivery System
Yuanzeng Min et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Multifunctional Mesoporous Silica Nanocomposite Nanoparticles for Theranostic Applications
Ji Eun Lee et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
Osteostatin-loaded bioceramics stimulate osteoblastic growth and differentiation
Daniel Lozano et al.
ACTA BIOMATERIALIA (2010)
Reactive oxygen species in cancer
Geou-Yarh Liou et al.
FREE RADICAL RESEARCH (2010)
Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications
Jinjun Shi et al.
NANO LETTERS (2010)
Buthionine Sulfoximine, an Experimental Tool to Induce Glutathione Deficiency: Elucidation of Glutathione and Ascorbate in Their Role as Antioxidants
Harry P. Broquist
NUTRITION REVIEWS (2010)
Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems
Supratim Giri et al.
NANOMEDICINE (2007)
Glutathione metabolism and its implications for health
GY Wu et al.
JOURNAL OF NUTRITION (2004)
Biochemical modulation of cisplatin mechanisms of action:: Enhancement of antitumor activity and circumvention of drug resistance
MA Fuertes et al.
CHEMICAL REVIEWS (2003)
Oral cancer and precancerous lesions
BW Neville et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2002)
Share Paper
